ranolazine has been researched along with Recrudescence in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosco, B; D'Andrea, D; Di Chiara, G; Iodice, P; Uran, C | 1 |
| Hui, Q; Luo, W; Ren, X; Ya, M; Yan, W; Yuan, C | 1 |
| Bontempi, L; Cerini, M; Curnis, A; Giacopelli, D; Inama, L; Raweh, A; Salghetti, F; Sciatti, E; Vassanelli, F; Villa, C; Vizzardi, E | 1 |
| Anastasiou-Nana, M; Dagres, N; Iliodromitis, EK; Karatzas, D; Lekakis, JP; Rallidis, LS; Simeonidou, E; Simitsis, P | 1 |
| Belardinelli, L; Farzaneh-Far, R; Gutierrez, JA; Karwatowska-Prokopczuk, E; Morrow, DA; Murphy, SA; Scirica, BM; Walker, G | 1 |
| Nguyen, E; White, CM | 1 |
| Braunwald, E; Chaitman, BR; Karwatowska-Prokopczuk, E; McCabe, CH; McGuire, DK; Morrow, DA; Murphy, SA; Scirica, BM | 1 |
| Bonaca, MP; Braunwald, E; Chamberlin, JS; Jarolim, P; Morrow, DA; Murphy, SA; Rhodes, DW; Sabatine, MS; Scirica, BM; Southwick, PC | 1 |
| Braunwald, E; Budaj, A; Karwatowska-Prokopczuk, E; McCabe, CH; Morrow, DA; Murphy, SA; Scirica, BM; Skene, A; Varshavsky, S; Wolff, AA | 1 |
| Melloni, C; Newby, LK | 1 |
2 review(s) available for ranolazine and Recrudescence
| Article | Year |
|---|---|
Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
Topics: Acetanilides; Acute Coronary Syndrome; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Coronary Artery Bypass; Electric Countershock; Humans; Piperazines; Ranolazine; Recurrence | 2014 |
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Clinical Trials as Topic; Dronedarone; Drug Therapy, Combination; Humans; Male; Ranolazine; Recurrence; Treatment Outcome | 2017 |
3 trial(s) available for ranolazine and Recrudescence
| Article | Year |
|---|---|
Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Double-Blind Method; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Ranolazine; Recurrence; Sodium Channel Blockers; Treatment Outcome | 2015 |
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Cardiovascular Agents; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Recurrence | 2009 |
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Topics: Acetanilides; Aged; Angina Pectoris; Cardiovascular Agents; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Proportional Hazards Models; Ranolazine; Recurrence | 2007 |
5 other study(ies) available for ranolazine and Recrudescence
| Article | Year |
|---|---|
A case of vasospastic angina. Vasospasm physiopathology: a new therapeutic role for ranolazine?
Topics: Adult; Aftercare; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Angiography; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Echocardiography; Humans; Male; Ranolazine; Recurrence; Sodium Channel Blockers; Treatment Outcome | 2020 |
Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Meta-Analysis as Topic; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Recurrence; Risk Assessment; Secondary Prevention; Sodium Channel Blockers; Treatment Outcome | 2021 |
Ranolazine therapy in drug-refractory ventricular arrhythmias.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Disease Progression; Drug Resistance; Electric Countershock; Female; Heart Failure; Humans; Male; Middle Aged; Ranolazine; Recurrence; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2017 |
Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; Cause of Death; Electrocardiography; Enzyme Inhibitors; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Piperazines; Predictive Value of Tests; Pregnancy; Pregnancy-Associated Plasma Protein-A; Prognosis; Prospective Studies; Ranolazine; Recurrence; Risk Assessment; Signal Processing, Computer-Assisted; Survival Analysis; Troponin | 2012 |
Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Topics: Acetanilides; Acute Coronary Syndrome; Acute Disease; Angina Pectoris; Cardiovascular Agents; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Quality of Life; Randomized Controlled Trials as Topic; Ranolazine; Recurrence; Sex Factors; Thrombolytic Therapy | 2008 |